Mining's Dark Days: Bitcoin Companies Dump BTC and Pivot to AI to Survive
Bitcoin mining profits have tanked with BTC down ~50% from its 2025 peak. Miners like Core Scientific are selling holdings and shifting to AI to stay alive in tough times.
Bitcoin mining profits have tanked with BTC down ~50% from its 2025 peak. Miners like Core Scientific are selling holdings and shifting to AI to stay alive in tough times.
The US is considering capping AI chip exports like Nvidia's H200 and AMD's MI325 to just 75,000 units per Chinese company. This news is pressuring stocks amid ongoing trade tensions and global market worries.
TransCode Therapeutics (RNAZ) announces an exclusive license for advanced cancer immunotherapy tech from Unleash, targeting hard-to-treat bladder cancer and more, in an all-stock deal to expand their pipeline.
Mobix Labs secures significant order for Tomahawk missile components as U.S. Navy ramps up production—stock surges on defense demand boost.
Theravance Biopharma's ampreloxetine failed its Phase 3 CYPRESS study for nOH in MSA. Company winds down program, cuts costs ~60%, focuses on YUPELRi cash flow, and speeds up strategic alternatives review to maximize shareholder value.
AeroVironment invests $30M+ in Albuquerque manufacturing, creating 450+ jobs, while negotiating SCAR program contract amendment with U.S. Space Force for faster satellite comms delivery.